A Clinical Study on the Level of Serum Low Progesterone about Luteal Phase Support for Partial Vaginal Delivery in Assisted Reproductive Technology

Zhou Yuanping,Wu Xiaoyun,Zhu Yurong,Xu Jian
DOI: https://doi.org/10.3760/cma.j.issn.2096-2916.2017.11.002
2017-01-01
Abstract:Objective To investigate the effects of low progesterone levels on the clinical efficacy of the luteal support protocol by using vaginal progesterone gel in assisted reproductive technology (ART).Methods A total of 624 cycles of frozen-thawed embryo transfer (FET) with hormone replacement were performed in our center from June 2012 to December 2016.They were divided into two groups according to the difference in the post luteal support protocol:group A (progesterone vaginal sustained release gel + dydrogesterone) 348 cycles and group B (progesterone injection + dydrogesterone) 276 cycles.The serum progesterone levels and pregnancy outcome were compared in the two groups of pregnant and non-pregnant women with 14 d after embryo transfer.Results 1) There were no significant differences in serum progesterone levels between the pregnant and non-pregnant groups in group A after 14 d of transplantation (P>0.05).The level of serum progesterone in group B [(74.08±24.80) nmol/L] was significantly higher than that of non-pregnant women [(62.28 ±29.34) nmol/L] after 14 d of transplantation,and the difference was statistically significant (P<0.05).2) The progesterone level in group A [(16.074±9.40) nmol/L] was significantly lower than that in group B,the difference was statistically significant (P<0.05).3) The rate of embryo implantation,the rate of clinical pregnancy,the rate of early abortion and the rate of ectopic pregnancy were not statistically different between the two groups (P>0.05).Conclusion Progesterone vaginal sustained-release gel as a luteal support in the treatment of embryo transfer,has the same efficacy with intramuscular progesterone injection.But because it has the first-pass effect of uterus,the expression level in serum is low,so the monitoring of serum progesterone level is not needed.
What problem does this paper attempt to address?